抗生素英文课件-Choosing-Antibiotics-Before-and-After-t.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《抗生素英文课件-Choosing-Antibiotics-Before-and-After-t.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 抗生素 英文 课件 Choosing Antibiotics Before and After
- 资源描述:
-
1、Choosing Antibiotics:Before and After the Culture ResultsGopi Patel,MDAugust 20,2010ProphylaxisEmpiricTargetedPicking AntibioticsWhat has the patient grown before?What is the patient growing now?What is the patient at risk for growing?What are the patients signs and symptoms?Antibiotic selectionRisk
2、 factors for drug resistance Recent antimicrobial exposuresUnderlying comorbidities AllergiesRecent interventionsAvailable and previous culture data History of MRSA,VRE,Pseudomonas ESBL-producing GNRThe flora and fauna of the hospital And perhaps even the unit How sick is the patient?Can always“go b
3、ig”and narrow as you get more informationJust to refresh your memoryCephalosporins*1stCefazolinCephalexin Gram-positive cocci(e.g.,MSSA,GBS)E.coli,K.pneumoniae,P.mirabilis2ndCefuroximeCefoxitinCefotetan Cefuroxime-H.influenzae Cephamycins-Bacteroides spp3rdCefotaximeCeftriaxoneCeftazidime Some anaer
4、obic coverage Ceftazidime-Pseudomonas Crosses the BBB Potent inducers of-lactamases4thCefepime Pseudomonas Crosses the BBB Stable against many-lactamases*Do NOT cover Enterococcus,Listeria,Legionella,or MRSACase 1 48 M IVDA admitted with fevers and chills Fresh track marks on Left arm Febrile to 39
5、BP 70/55 HR 112 93%RA III/VI systolic murmur at LLSB B/L crackles Chest X-ray-Congestion B/L Empiric antibiotics?As expected At 14 hours both sets of blood cultures are growing Gram-positive cocci in clusters Previous history of MRSA TTE cant rule out vegetation on mitral valve TEE refused Patient g
6、rows MRSA Vancomycin continuedVancomycin Discovered in 1956 Mechanism of action Inhibits bacterial cell wall synthesis Binds firmly to D-Ala-D-Ala of the peptidoglycan,preventing elongation and cross-linking Mechanism of resistance Altered peptidoglycan binding site D-Ala-D-Ala is replaced by D-Ala-
7、D-lactate Thickened cell wallToxicity Nephrotoxicity Most often in the setting of other nephrotoxic agents and unstable renal function Hypersensitivity reactions1 Red man syndrome Anaphylaxis Rare reactions Ototoxicity Neutropenia and/or thrombocytopenia2 Linear IgA bullous dermatosis1 Crit Care.200
8、3;7(2)119-202 NEJM.2007;356(9)904-910Linear IgA Bullous DermatosisDosingDosingCrCl(mL/min)Dosing Regimen 7015 mg/kg every 8-12 hours40-6915 mg/kg every 12-24 hours 10 mg/L Minimum troughs of 15-20 mg/L are recommended for severe or complicated infections(endocarditis,osteomyelitis,meningitis,and pne
9、umonia)1 Am J Resp Crit Care Med.2005;171:338.2 Clin Infect Dis.2004;39:1267-84.3 Circulation.2005;111:e394-e433.What if a person cant“tolerate”Vanco?-Anaphylaxis-Patient“refuses”drug-Cant get the right levels-Ease of dosingDaptomycin FDA approved in 2003 Depolarizes the cell membrane and is rapidly
10、 bactericidal against Gram-positives Approved for the treatment of complicated skin and skin structure infections S.aureus(including MRSA),GAS,Streptococcus agalactiae,and vanco-susceptible Enterococcus faecalis Not approved for E.faecium(CLSI breakpoint 4)Non-inferior to vanco and anti-staph penici
11、llins in S.aureus bacteremia and right-sided endocarditis1 Jury is out for left-sided endocarditis NOT indicated for treatment of pneumonia1 NEJM.2006;355(7):652-65 Dosing Use actual body weight For serious,life-threatening infections dosing regimens of 8 to 12 mg/kg have been used1 Requires 24-hour
12、 Antibiotic ApprovalIndicationCrCl(mL/min)DoseSSTI 30 30(HD)4 mg/kg every 24 hrs4 mg/kg every 48 hrsBacteremia 30100,000 CFU/mL GRAM NEGATIVE BACILLIIsolate 01 Klebsiella pneumoniae,an ESBL producerCONTACT PRECAUTIONSANTIBIOTICS Mic SYSTEMIC URINE Aztreonam 16 R Ceftriaxone 16 R*Cefepime 16 R*Cefuro
13、xime 16 R*Tetracycline 4 S Ertapenem 2 S Gentamicin 4S Imipenem 4 S Levofloxacin 2 S Trimethoprim/Sulf16 R Ceftriaxone 16 R*Cefepime 16 R*Cefuroxime 16 R*Tetracycline 4 S Ertapenem 2 S Gentamicin 4S Imipenem 2 R Trimethoprim/Sulf16/8 R Aztreonam 16 R Ceftriaxone 32 R Ceftazidime 16 R Ciprofloxacin 2
展开阅读全文
链接地址:https://www.163wenku.com/p-5110777.html